NextCure, Inc. (NXTC) reporting calendar
NextCure, Inc. files periodic reports with the SEC as NXTC on Nasdaq. Atlas tracks 29 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 20 Jul 2026 – 23 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 29
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open NXTC market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001104659-26-057187 |
| 10-K | 31 Dec 2025 | 5 Mar 2026 | 64 days | 0001104659-26-024137 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001104659-25-107036 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0001558370-25-010782 |
| 10-Q | 31 Mar 2025 | 1 May 2025 | 31 days | 0001558370-25-006111 |
| 10-K | 31 Dec 2024 | 6 Mar 2025 | 65 days | 0001558370-25-002402 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0001558370-24-014869 |
| 10-Q | 30 Jun 2024 | 1 Aug 2024 | 32 days | 0001558370-24-010605 |
| 10-Q | 31 Mar 2024 | 2 May 2024 | 32 days | 0001558370-24-006551 |
| 10-K | 31 Dec 2023 | 21 Mar 2024 | 81 days | 0001558370-24-003672 |
| 10-Q | 30 Sep 2023 | 2 Nov 2023 | 33 days | 0001558370-23-017429 |
| 10-Q | 30 Jun 2023 | 3 Aug 2023 | 34 days | 0001558370-23-013250 |
| 10-Q | 31 Mar 2023 | 4 May 2023 | 34 days | 0001558370-23-008131 |
| 10-K | 31 Dec 2022 | 2 Mar 2023 | 61 days | 0001558370-23-002698 |
| 10-Q | 30 Sep 2022 | 3 Nov 2022 | 34 days | 0001558370-22-016275 |
| 10-Q | 30 Jun 2022 | 4 Aug 2022 | 35 days | 0001558370-22-012232 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0001558370-22-007439 |
| 10-K | 31 Dec 2021 | 3 Mar 2022 | 62 days | 0001558370-22-002824 |
| 10-Q | 30 Sep 2021 | 4 Nov 2021 | 35 days | 0001558370-21-014632 |
| 10-Q | 30 Jun 2021 | 5 Aug 2021 | 36 days | 0001558370-21-010578 |
| 10-Q | 31 Mar 2021 | 6 May 2021 | 36 days | 0001558370-21-006266 |
| 10-K | 31 Dec 2020 | 4 Mar 2021 | 63 days | 0001558370-21-002384 |
| 10-Q | 30 Sep 2020 | 5 Nov 2020 | 36 days | 0001558370-20-012866 |
| 10-Q | 30 Jun 2020 | 6 Aug 2020 | 37 days | 0001558370-20-009660 |
| 10-Q | 31 Mar 2020 | 7 May 2020 | 37 days | 0001558370-20-005800 |
| 10-K | 31 Dec 2019 | 12 Mar 2020 | 72 days | 0001558370-20-002566 |
| 10-Q | 30 Sep 2019 | 12 Nov 2019 | 43 days | 0001558370-19-010701 |
| 10-Q | 30 Jun 2019 | 12 Aug 2019 | 43 days | 0001558370-19-007974 |
| 10-Q | 31 Mar 2019 | 10 Jun 2019 | 71 days | 0001558370-19-005589 |
Source: SEC EDGAR company submissions for CIK 0001661059. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.